Takeda Pharmaceutical Company Limited (TAK) Ownership
TAK ownership summary
as of October 18, 2026- Institutions
- 3.3% of shares outstanding
- Insiders
- 0.08% of shares outstanding
- Shares outstanding
- 3.19B
- Float
- 3.16B shares available to trade
- Short interest
- 0.09% 2.9M shares short
- Days to cover
- 1.28 short interest down 28.6% vs prior month
- Institutions 3.31%
- Insiders 0.08%
- Other investors 96.61%
TAK top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Capital Research Global Investors | 0.60% | 19.3M | $379.6M | +193,461 (+1.0%) | June 30, 2026 |
| 2 | FMR Inc | 0.30% | 9.6M | $188.8M | +2.5M (+34.9%) | June 30, 2026 |
| 3 | Morgan Stanley - Brokerage Accounts | 0.22% | 7.0M | $137.6M | +525,324 (+8.1%) | June 30, 2026 |
| 4 | Adage Capital Partners Gp LLC | 0.19% | 6.1M | $119.0M | −374,213 (−5.8%) | June 30, 2026 |
| 5 | The Goldman Sachs Group Inc | 0.16% | 5.1M | $100.8M | −493,696 (−8.8%) | June 30, 2026 |
| 6 | Brandes Investment Partners & Co | 0.14% | 4.5M | $89.3M | +108,705 (+2.5%) | June 30, 2026 |
| 7 | Arrowstreet Capital Limited Partnership | 0.12% | 3.7M | $73.4M | +616,613 (+19.8%) | June 30, 2026 |
| 8 | BlackRock Inc | 0.12% | 3.7M | $72.5M | +511,745 (+16.1%) | June 30, 2026 |
| 9 | Renaissance Technologies Corp | 0.08% | 2.6M | $50.5M | −421,100 (−14.1%) | June 30, 2026 |
| 10 | Qube Research & Technologies | 0.07% | 2.2M | $43.4M | +2.2M (0.0%) | June 30, 2026 |
| 11 | First Trust Advisors L.P. | 0.07% | 2.1M | $41.6M | +143,838 (+7.3%) | June 30, 2026 |
| 12 | D. E. Shaw & Co LP | 0.06% | 2.0M | $40.3M | −553,076 (−21.3%) | June 30, 2026 |
| 13 | Managed Asset Portfolios, LLC | 0.06% | 1.8M | $35.9M | +25,486 (+1.4%) | June 30, 2026 |
| 14 | Northern Trust Corp | 0.05% | 1.7M | $34.2M | −220,725 (−11.3%) | June 30, 2026 |
| 15 | Van Eck Associates Corporation | 0.05% | 1.7M | $32.9M | −586,099 (−25.9%) | June 30, 2026 |
| 16 | AQR Capital Management LLC | 0.05% | 1.5M | $30.0M | +631,263 (+70.6%) | June 30, 2026 |
| 17 | Quantinno Capital Management LP | 0.04% | 1.4M | $27.6M | +113,324 (+8.8%) | June 30, 2026 |
| 18 | Wells Fargo & Co | 0.04% | 1.2M | $22.6M | +14,798 (+1.3%) | June 30, 2026 |
| 19 | Millennium Management LLC | 0.03% | 1.1M | $20.7M | +1.1M (0.0%) | June 30, 2026 |
| 20 | UBS Group AG | 0.03% | 911K | $17.9M | −1.8M (−66.7%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 13 holders added 8.6M shares and 7 cut 4.5M.
TAK top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | American Funds American Mutual A | 0.57% | 18.2M | $357.2M | — | September 30, 2026 |
| 2 | American Funds Capital Inc Bldr A | 0.23% | 7.3M | $144.5M | +7.3M (0.0%) | September 30, 2026 |
| 3 | First Trust Value Line® Dividend ETF | 0.05% | 1.7M | $33.7M | — | September 30, 2026 |
| 4 | VanEck Pharmaceutical ETF | 0.05% | 1.5M | $29.9M | −8,183 (−0.5%) | September 30, 2026 |
| 5 | Steward Values Enhanced International I | 0.02% | 712K | $14.0M | — | August 31, 2026 |
| 6 | Avantis International Equity ETF | 0.02% | 553K | $10.9M | — | September 30, 2026 |
| 7 | Mercer Non-US Core Equity Y3 | 0.02% | 514K | $10.1M | −53,301 (−9.4%) | September 30, 2026 |
| 8 | ActivePassive International Equity ETF | 0.01% | 178K | $3.5M | — | September 30, 2026 |
| 9 | Catalyst/MAP Global Equity A | 0.01% | 169K | $3.3M | — | June 30, 2026 |
| 10 | VALMXVL B1 | <0.01% | 148K | $2.9M | — | September 30, 2026 |
| 11 | Vanguard FTSE All-Wld ex-US ETF | <0.01% | 123K | $2.4M | — | August 31, 2026 |
| 12 | Carillon Chartwell Real Income I | <0.01% | 120K | $2.4M | −40,000 (−25.0%) | September 30, 2026 |
| 13 | American Funds IS® Capital Inc Builder®2 | <0.01% | 104K | $2.0M | +104,073 (0.0%) | September 30, 2026 |
| 14 | Middlefield Healthcare Dividend ETF | <0.01% | 91K | $1.8M | +91,400 (0.0%) | September 30, 2026 |
| 15 | Middlefield Healthcare Dividend F | <0.01% | 79K | $1.5M | +78,600 (0.0%) | September 30, 2026 |
| 16 | iShares Dynamic Equity Active ETF | <0.01% | 77K | $1.5M | +39 (+0.1%) | September 25, 2026 |
| 17 | Strategic Advisers International | <0.01% | 66K | $1.3M | — | August 31, 2026 |
| 18 | iShares Flexible Equity Active ETF | <0.01% | 64K | $1.3M | — | September 30, 2026 |
| 19 | Adasina Social Justice All Cp Glbl ETF | <0.01% | 61K | $1.2M | +1,350 (+2.3%) | September 30, 2026 |
| 20 | SGI Global Equity I | <0.01% | 45K | $889,812 | −1,619 (−3.5%) | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
TAK insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-24 | Pharmaceutical Co Ltd Takeda | Sell | $8.10 | 3,703,703 | $30.0M |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
TAK shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns TAK
Institutional investors own 3.3% of Takeda Pharmaceutical's shares and insiders 0.08%. The largest holder is Capital Research Global Investors with 0.60% of the shares (19.3M), as of June 30, 2026. Among the top 20 institutions, 13 added shares and 7 reduced their stake in the latest filings. Short interest is 0.09% of the float, or 1.28 days of average trading volume. The share count rose 2.2% since 2014.
Related: TAK analyst forecast, TAK key metrics, TAK dividend history. See the TAK stock overview for the latest quote and news.
TAK ownership FAQ
Who owns the most Takeda Pharmaceutical stock?
The largest shareholders of Takeda Pharmaceutical are Capital Research Global Investors (0.60%), FMR Inc (0.30%), Morgan Stanley - Brokerage Accounts (0.22%), Adage Capital Partners Gp LLC (0.19%), The Goldman Sachs Group Inc (0.16%).
What percentage of Takeda Pharmaceutical is owned by institutions?
Institutions hold 3.3% of Takeda Pharmaceutical's shares outstanding; insiders hold 0.08%.
Which funds own Takeda Pharmaceutical?
The largest fund holders of Takeda Pharmaceutical are American Funds American Mutual A (0.57%), American Funds Capital Inc Bldr A (0.23%), First Trust Value Line® Dividend ETF (0.05%), VanEck Pharmaceutical ETF (0.05%), Steward Values Enhanced International I (0.02%).
What is Takeda Pharmaceutical's short interest?
2.9M shares of Takeda Pharmaceutical were sold short, 0.09% of the float; at the average daily volume it would take 1.28 days to cover.
Are insiders buying or selling Takeda Pharmaceutical?
Of the latest 1 reported insider transactions in Takeda Pharmaceutical (since January 24, 2024), 0 were purchases and 1 were sales.
How many shares of Takeda Pharmaceutical are outstanding?
Takeda Pharmaceutical has 3.19B shares outstanding, of which 3.16B are in the public float.